行业
显示 21-30 个结果(共 134 个结果)
-
Global Molecular Diagnostic Market
The global molecular diagnostic market is poised to grow by US$ 5,945 期间百万 2021-2027, 复合年增长率为 8.9% 在预测期内, 据数据和分析公司 StrategyHelix 称.
-
Chemiluminescence Immunoassay (CLIA) 中国市场
A statistic by StrategyHelix indicates that the chemiluminescence immunoassay (CLIA) market in China is expected to increase by US$ 7,883 百万来自 2021 到 2027, 复合年增长率为 17.4% 在预测期内.
-
Point of Care Testing (POCT) 中国市场
The point of care testing (POCT) 中国市场大约 1,855 百万美元 2020, 到达 2,235 百万美元 2021 (增加了 20.5% 去年同期), 根据StrategyHelix’ 分析.
-
Global Point of Care Testing (POCT) 市场
The global point of care testing (POCT) 市场就在附近 27 十亿美元 2020, 到达 30 十亿美元 2021 (增加了 9.4% 去年同期), 根据StrategyHelix’ 分析.
-
In vitro diagnostics (IVD) 中国市场
A statistic by StrategyHelix indicates that the in vitro diagnostics (IVD) market in China is anticipated to expand positively at a CAGR of 15.6% 在预测期内 (2021-2027).
-
Global In vitro diagnostics (IVD) 市场
A statistic by StrategyHelix indicates that the global in vitro diagnostics (IVD) market is set to grow at a healthy compound annual growth rate (复合年增长率) 的 7% 未来五年.
-
Assisted Reproduction Market in China
The assisted reproduction market in China is set to increase by US$ 9,271 百万来自 2021 到 2027, 代表复合年增长率 (复合年增长率) 的 14.2% 在预测期内.
-
Drugs for Helicobacter Pylori Infection Market in China
The drugs for helicobacter pylori infection market in China is set to increase by US$ 5,855 百万来自 2021 到 2027, 代表复合年增长率 (复合年增长率) 的 14.2% 在预测期内.
-
Inhalation Preparations Market in China
The inhalation preparations market in China is poised to grow by US$ 3,951 期间百万 2021-2027, 复合年增长率为 12.8% 在预测期内, 据数据和分析公司 StrategyHelix 称.
-
Drug for Gastrointestinal Diseases Market in China
根据StrategyHelix, the drug for gastrointestinal diseases market in China is expected to increase by US$ 4,900 期间百万 2021-2027, 复合年增长率为 6.7% 在预测期内.